Other languages Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Real-time Estimate Cboe BZX Other stock markets 14:49:23 03/05/2024 BST			5-day change	1st Jan Change
2.305 ^USD	+6.22%		+12.25%	-31.23%

04-24	Coherus BioSciences, Inc. Announces Presentation of Clinical Data for CHS-114 at 2024 American Society of Clinical Oncology Annual Meeting	CI
03-20	HC Wainwright Adjusts Coherus BioSciences' Price Target to $11 From $13, Keeps Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Coherus BioSciences, Inc. Announces Presentation of Clinical Data for CHS-114 at 2024 American Society of Clinical Oncology Annual Meeting	04-24
Coherus BioSciences Shares Fall After Workforce Reduction Plan; Q4 Loss	03-14
Coherus Biosciences : Delta Airlines, KKR...les valeurs à suivre aujourd'hui à Wall Street -	03-14
Coherus Biosciences : trébuche au quatrième trimestre	03-14
Coherus BioSciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-13
Bourse Zurich: le SMI ne parvient pas à remonter la pente	03-04
Sandoz : finalise en avance le rachat du Cimerli	03-04
Coherus BioSciences Completes $170 Million Sale of Ophthalmology Franchise to Sandoz	03-04
L'IA, si t'en as pas, t'as raté ta vie (boursière)	03-04
Bourse Zurich: ouverture indécise attendue, malgré les records à Wall Street	03-04
En direct des Marchés : BNP Paribas, Saint-Gobain, Super Micro Computer, Zozo, SoftwareOne...	03-04
Sandoz : acquisition de Cimerli finalisée	03-04
EN DIRECTO DESDE LOS MERCADOS: Santander, Endesa, Acciona, Amadeus, Repsol, Evonik, Geox, Volkswagen...	03-04
Sandoz schliesst Übernahme von Biosimilar Cimerli erfolgreich ab	03-04
Sandoz Completes Purchase of Retinal Disease Medication Cimerli from Coherus BioSciences	03-04
Sandoz finalise la reprise d'un générique du Lucentis à Coherus	03-04
Sandoz Inc. completed the acquisition of CIMERLI an ophthalmology franchise from Coherus BioSciences, Inc..	02-29
Coherus Biosciences, Inc. Appoints Georgia Erbez to Board of Directors	02-22
Coherus BioSciences, Inc. Announces U.S. Launch of UDENYCA ONBODY a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv	02-21
KKR to acquire a stake in health tech firm Cotiviti	02-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Other languages

Filters